HEARTS Package Evaluation Trial in Bangladesh

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3935 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-09

Study Completion Date

2022-08-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypertension became the leading risk factor of death globally as well as in Bangladesh. Uncontrolled hypertension is the key challenge for the success of a hypertension control programs. According to the last national STEPS Survey in Bangladesh, hypertension control rate is only 11%. World Health Organization promoted the HEARTS technical package for the hypertension control programs to improve the control scenario. National Heart Foundation of Bangladesh is implementing a hypertension control program in selected Upazilas (sub-districts) of Bangladesh in collaboration with Non-Communicable Disease Control (NCDC) Program of Directorate General of Health Services (DGHS) and Resolve to Save Lives, USA. Proposed quasi experimental study will be conducted in collaboration with NCDC of DGHS, Resolve to Save Lives, USA and Johns Hopkins University, Baltimore with an objective of to evaluate the impact of HEARTS package on the rate of hypertension control in primary health care centers in Bangladesh. In this study equal number of hypertensive adult patients will be recruited in Upazila Health Complexes of control and intervention groups with a hypothesis of, implementation of HEARTS technical package in primary health care centers can reduce the blood pressure significantly. After obtaining informed written consent, respondents' basic demographic information, history of antihypertensive medication intake and related comorbidities will be taken. Blood pressure measurements data will be recorded also. All of these data will be collected via a secured mobile application, Simple App. Collected data will be preserved in a secured cloud based database. After six months of enrolment, and end-line data will be collected at the community setup, preferably at the home of respondents, following standard techniques of BP measurement by experienced Field Research Assistants. During whole of the study procedure, every ethical right of the participants will be preserved with an utmost priority. De-identified data will be shared with the partner organizations for further scientific analysis. This study will generate robust evidence for use of HEARTS technical packages in low-and middle-income countries, like Bangladesh, especially at low-level health facilities and provide guidance for designing and implementation of other hypertension control programs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Community-based HEARTS Intervention (Pilot)

NCT05954884

Hypertension

UNKNOWN NA

Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction

NCT07331220

Heart Failure With Preserved Ejection Fraction

NOT_YET_RECRUITING NA

Clinical Study of Active Intervention in High-risk HFpEF Patients

NCT06532019

Heart Failure With Preserved Ejection Fraction

NOT_YET_RECRUITING NA

One Heart to Care for

NCT04753398

Heart Failure

WITHDRAWN NA

Short Term Outcome of Acute Heart Failure in Diabetic and Non Diabetic Patients

NCT06447467

Acute Heart Failure Diabetes Mellitus

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Equal number of participants will be recruited simultaneously in both group of control and intervention. After certain time period of intervention participants of both groups will be evaluated and the differences of outcome will be measured.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Arm

Participants of this arm will not receive the total WHO HEARTS package as an intervention. These participants will be screened in the designated area for universal BP screening via A\&D arm-in device. Their diagnosis will be confirmed by measuring their BP by a Medical Officer via an Omron desktop oscillometer. The Medical Officers and UHC nurses of the control sites will be trained up on BP measurement using standard techniques, patient registration, data collection, etc.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention Arm

Participants of this arm will receive all the components of WHO HEARTS technical package components as an intervention.

Group Type EXPERIMENTAL

WHO HEARTS technical package

Intervention Type OTHER

Components of WHO HEARTS technical package are

1. Universal BP screening via A\&D arm-in BP device.
2. Training of Medical Officers and Nurses on BP measurement using standard techniques.
3. Training of the nurses on screening, registration data collection via the Simple mobile smart-phone digital clinical hypertension information application.
4. Use of a drug and dose specific hypertension treatment protocol.
5. Standardized inventory and procurement practice to ensure a reliable supply of protocol medications.
6. Training and support for team-based model of hypertension care delivery.
7. Access to the Simple data dashboard for program monitoring.
8. Standardized procedure for patient follow-up.
9. Community-based prescription refilling.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

WHO HEARTS technical package

Components of WHO HEARTS technical package are

1. Universal BP screening via A\&D arm-in BP device.
2. Training of Medical Officers and Nurses on BP measurement using standard techniques.
3. Training of the nurses on screening, registration data collection via the Simple mobile smart-phone digital clinical hypertension information application.
4. Use of a drug and dose specific hypertension treatment protocol.
5. Standardized inventory and procurement practice to ensure a reliable supply of protocol medications.
6. Training and support for team-based model of hypertension care delivery.
7. Access to the Simple data dashboard for program monitoring.
8. Standardized procedure for patient follow-up.
9. Community-based prescription refilling.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 and above
* Have a diagnosis of hypertension (inclusive of known prior diagnosis or a new diagnosis), with a baseline systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg
* Eligible for the HEARTS technical package, i.e., are not pregnant, not being treated for an acute illness or medical emergency, and do not have a terminal illness.

Exclusion Criteria

* Previously diagnosed hypertensive patients with a controlled BP at the time of enrollment (systolic BP \<140 mmHg and diastolic BP \< 90 mmHg). Either BP is controlled using diet and lifestyle measures or BP is controlled on antihypertensive medications,
* Cognitive impairment that would prevent comprehension of and responding to questions

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No